Pharmaceuticals

Latest California Healthline Stories

KHN’s ‘What The Health?’: How Will We Reopen The Economy?

The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’

The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.

Why Hoarding Of Hydroxychloroquine Needs To Stop

Six states — Idaho, Louisiana, Nevada, North Carolina, Ohio and Texas —  have taken steps to limit inappropriate prescriptions for the medicine and preserve supplies for patients who take it for lupus and rheumatoid arthritis.

Heart Association Puts Halt To Bayer’s Giant Displays Of Baby Aspirin

After Kaiser Health News’ questions, the association tells the aspirin maker to take down display bins at Walmart pharmacies that gave a false impression that the over-the-counter drug is recommended for everyone to prevent heart attacks.

Colorado Forges Ahead On A New Model For Health Care While Nation Waits

Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.